Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$14.25 – $26.00
39% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $367.96B | $333.37B | $297.18B | $335.14B | $426.68B | $435.08B | $438.27B | $502.82B |
| Cost of revenue | $54.88B | $56.78B | $52.52B | $55.41B | $62.25B | $57.60B | $63.83B | $89.11B |
| Gross profit | $308.84B | $276.59B | $244.65B | $279.72B | $364.44B | $377.48B | $374.44B | $413.72B |
| Gross margin | 83.9% | 83.0% | 82.3% | 83.5% | 85.4% | 86.8% | 85.4% | 82.3% |
| R&D | $52.06B | $47.95B | $54.25B | $73.00B | $102.39B | $102.64B | $108.61B | $123.62B |
| Operating income | $145.08B | $130.63B | $117.44B | $110.31B | $149.00B | $153.31B | $156.60B | $162.40B |
| EBITDA | $187.20B | $175.25B | $158.74B | $143.46B | $242.00B | $223.31B | $230.71B | $189.53B |
| Net income | $137.19B | $122.19B | $111.86B | $114.19B | $184.97B | $162.03B | $170.44B | $206.45B |
| Net margin | 37.3% | 36.7% | 37.6% | 34.1% | 43.3% | 37.2% | 38.9% | 41.1% |
| EPS (diluted) | 420.69 | 395.28 | 364.89 | 378.62 | 621.09 | 558.32 | 600.98 | 242.87 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $700.5B | $258.91 | $247.66–$275.66 | 2 |
| 2028 | $733.8B | $279.07 | $266.95–$297.13 | 3 |
| 2029 | $744.2B | $275.08 | $263.13–$292.88 | 4 |
| 2030 | $734.8B | $290.83 | $278.20–$309.65 | 2 |
Forward consensus · source: Financial Modeling Prep
SHIONOGI & CO LTD
No one on the platform currently holds SGIOF.
No tracked institution reports a position in SGIOF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $38.0000 | |
| 2026-09-30 | $38.0000 | |
| 2026-03-31 | $38.0000 | 2026-06-25 |
| 2025-09-30 | $33.0000 | 2025-12-01 |
| 2025-03-31 | $33.0000 | 2025-06-19 |
| 2024-09-30 | $85.0000 | 2024-12-02 |
| 2024-03-28 | $85.0000 | 2024-06-21 |
| 2023-09-29 | $75.0000 | 2023-12-01 |
| Execution date | Ratio |
|---|---|
| 2024-09-27 | 3-for-1 |
No one on the platform has traded SGIOF yet.
| +0.00% |
| $11.2B |
| — |
| FMCQFFresenius Medical Care AG | $45.17 | +0.00% | $12.1B | — |
| OCPNFOlympus Corporation | $10.01 | +0.00% | $11.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.1× earnings vs its 0.0× historical median P/E.
Fair value ≈ $10.12 · price $18.80 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.